Trial intelligence / Profile preview

Continuous versus single-shot interscalene block for pain control after minor shoulder surgery

ACTRN12616000095460Phase 4Not yet recruiting

Sponsor
Wellington Hospital Orthopaedic Department
Start
Mar 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Wellington Hospital Orthopaedic Department. Primary endpoint: Subjective pain score by visual analogue scale. Planned start Mar 2016; status: not yet recruiting.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ACTRN12616000095460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616000095460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call